1. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
- Author
-
Selak, Vanessa, Elley, C. Raina, Bullen, Chris, Crengle, Sue, Wadham, Angela, Rafter, Natasha, Parag, Varsha, Harwood, Matire, Doughty, Robert N., Arroll, Bruce, Milne, Richard J., Bramley, Dale, Bryant, Linda, Jackson, Rod, and Rodgers, Anthony
- Subjects
CARDIOVASCULAR diseases risk factors ,COMBINATION drug therapy ,CONFIDENCE intervals ,PATIENT compliance ,PROBABILITY theory ,RESEARCH funding ,SELF-evaluation ,RANDOMIZED controlled trials ,RELATIVE medical risk ,DESCRIPTIVE statistics - Abstract
STUDY QUESTION Can one tablet containing aspirin, statin, and blood pressure lowering agents improve adherence and risk factor control compared with usual care of patients at high risk of cardiovascular disease in primary care? SUMMARY ANSWER Fixed dose combination treatment improved adherence to all the recommended drugs, but improvements in clinical risk factors were small and did not reach statistical significance. WHAT IS KNOWN AND WHAT THIS PAPER ADDS Two recent long term trials indicate large improvements in self reported adherence to the recommended drugs and modest improvements in risk factor control in high risk patients receiving fixed dose combination treatment. The main findings of this trial were consistent with those of the earlier trials, and acceptability for this treatment was high among general practitioners and patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF